These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6970769)

  • 1. Properties of sodium dodecyl sulfate-denatured Interleukin 2.
    Caplan B; Gibbs C; Paetkau V
    J Immunol; 1981 Apr; 126(4):1351-4. PubMed ID: 6970769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical characterization of lymphocyte-activating factor (LAF).
    Mizel SB
    J Immunol; 1979 Jun; 122(6):2167-72. PubMed ID: 312860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of human B cell growth factor.
    Mehta SR; Conrad D; Sandler R; Morgan J; Montagna R; Maizel AL
    J Immunol; 1985 Nov; 135(5):3298-302. PubMed ID: 3876383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quaternary structure of murine amyloid fibrils: fibril dissociation following exposure to sodium dodecyl sulfate and alkali].
    Bannikova EM; Sura VV
    Biull Eksp Biol Med; 1980 May; 89(5):546-8. PubMed ID: 7397334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The purification and properties of human T cell growth factor.
    Mier JW; Gallo RC
    J Immunol; 1982 Mar; 128(3):1122-7. PubMed ID: 6976987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse monoclonal IgA antibodies lack interchain disulfide bonds.
    Krotkiewski H; Laskowska A; Krotkiewska B
    Arch Immunol Ther Exp (Warsz); 1995; 43(3-4):167-72. PubMed ID: 8744690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translation of lymphocyte mRNA into biologically-active Interleukin 2 in oocytes.
    Bleackley RC; Caplan B; Havele C; Ritzel RG; Mosmann TR; Farrar JJ; Paetkau V
    J Immunol; 1981 Dec; 127(6):2432-5. PubMed ID: 6975322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical characterization of regulatory factors derived from T cell hybridomas and spleen cells. I. Separation of T cell growth factor and T cell replacing factor from granulocyte-macrophage colony-stimulating factor.
    Clark-Lewis I; Schrader JW
    J Immunol; 1982 Jan; 128(1):168-74. PubMed ID: 6976369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potency of IL2-caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease.
    Shteingart S; Rapoport M; Grodzovski I; Sabag O; Lichtenstein M; Eavri R; Lorberboum-Galski H
    Gut; 2009 Jun; 58(6):790-8. PubMed ID: 18978179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal cell (keratinocyte)-derived thymocyte-activating factor (ETAF).
    Luger TA; Stadler BM; Katz SI; Oppenheim JJ
    J Immunol; 1981 Oct; 127(4):1493-8. PubMed ID: 6974195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of factors inducing apoptosis in thymocytes of mice bearing a transplantable T-cell lymphoma of spontaneous origin.
    Shanker A; Singh SM
    Neoplasma; 2000; 47(2):90-5. PubMed ID: 10985473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells.
    Rabin H; Hopkins RF; Ruscetti FW; Neubauer RH; Brown RL; Kawakami TG
    J Immunol; 1981 Nov; 127(5):1852-6. PubMed ID: 6975300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal of sodium dodecyl sulfate from protein samples prior to matrix-assisted laser desorption/ionization mass spectrometry.
    Puchades M; Westman A; Blennow K; Davidsson P
    Rapid Commun Mass Spectrom; 1999; 13(5):344-9. PubMed ID: 10209872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of murine helper T cell-replacing factors.
    Watson J; Mochizuki D; Gillis S
    Prog Clin Biol Res; 1981; 66 Pt A():513-22. PubMed ID: 6975944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody against human interleukin 2 (IL 2). I. Purification of IL 2 for the production of monoclonal antibodies.
    Stadler BM; Berenstein EH; Siraganian RP; Oppenheim JJ
    J Immunol; 1982 Apr; 128(4):1620-4. PubMed ID: 6977565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptor site(s) for T cell-replacing factor (TRF) on B lymphocytes. I. TRF-substituting activity of anti-TRF acceptor site(s) antibody in the triggering of B cells.
    Takatsu K; Sano Y; Hashimoto N; Tomita S; Hamaoka T
    J Immunol; 1982 Jun; 128(6):2575-80. PubMed ID: 6978907
    [No Abstract]   [Full Text] [Related]  

  • 17. Structural and functional studies on the interaction of sodium dodecyl sulfate with beta-galactosidase.
    Muga A; Arrondo JL; Bellon T; Sancho J; Bernabeu C
    Arch Biochem Biophys; 1993 Jan; 300(1):451-7. PubMed ID: 8424679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and biologic characterization of lymphocyte regulatory molecules. VIII. Purification of interleukin 2 from a human T cell leukemia.
    Frank MB; Watson J; Mochizuki D; Gillis S
    J Immunol; 1981 Dec; 127(6):2361-5. PubMed ID: 6975318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of T cell-activating monokine of guinea pig macrophages induced by MDP and partial characterization of the monokine.
    Iribe H; Koga T; Onoue K
    J Immunol; 1982 Sep; 129(3):1029-32. PubMed ID: 6980914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A T cell-derived factor stimulating multipotential hemopoietic stem cells: molecular weight and distinction from T cell growth factor and T cell-derived granulocyte-macrophage colony-stimulating factor.
    Schrader JW; Clark-Lewis I
    J Immunol; 1982 Jul; 129(1):30-5. PubMed ID: 6979567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.